SI-BONE, Inc. (NASDAQ:SIBN) has scheduled a conference call for 2nd November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website si-bone.com
Earnings Expectation
SI-BONE, Inc. is reporting third quarter financial results on Monday 2nd November 2020, after market close.
According to analysts surveyed by Thomson Reuters, SIBN is expected to report 3Q20 loss of $ 0.39 per share from revenue of $ 16.42 million. For the full year, analysts anticipate top line of $ 68.48 million, while looking forward to loss of $ 1.6 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 20.10 million ~ $ 20.40 million
Full Year 2020 topline are forecasted in a range of$ 73.00 million ~ $ 74.00 million
Click Here For More Historical Outlooks Of SI-BONE, Inc.
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
